Back to search
Hospital-acquired Bacterial Pneumonia (HABP)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hospital-acquired Bacterial Pneumonia (HABP) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hospital-acquired Bacterial Pneumonia (HABP) trials you may qualify forThis is a two-part study, with Part A being the randomized, controlled portion of the study in patients with hospital-acquired bacterial pneumonia (HABP) or ven…
This is a phase 2a, multinational, multicenter, double-blind, randomized, placebo-controlled, dose-ranging safety, tolerability and PK study in patients with HA…
This study is to evaluate the efficacy and safety of Meropenem and Pralurbactam for Injection in Subjects with HABP/VABP. The primary objective is to demonstrat…
The study will evaluate the efficacy and safety of Meropenem and Pralurbactam versus Best Available Therapy in the treatment of Carbapenem-Resistant Enterobacte…
The purpose of this study is to evaluate the efficacy and safety of HRS -8427 in patients with HABP/VABP.
The primary purpose of this study is to understand the pharmacokinetics (PK) of single and multiple doses of cefiderocol in children from birth to less than 3 m…
This Phase IIb study aims to evaluate the safety and efficacy of BV100 in combination with low dose polymyxin B plus ceftazidime/avibactam or cefiderocol in pat…